Your browser doesn't support javascript.
loading
Canadian clinical experience on switching from standard half-life recombinant factor VIII (rFVIII), octocog alfa, to extended half-life rFVIII, damoctocog alfa pegol, in persons with haemophilia A ≥ 12 years followed in a Comprehensive Hemophilia Care Program in Canada.
Matino, Davide; Germini, Federico; Chan, Anthony K C; Decker, Kay; Iserman, Emma; Chelle, Pierre; Edginton, Andrea N; Oladoyinbo, Olayide; Trinari, Elisabetta; Keepanasseril, Arun; Iorio, Alfonso.
Afiliação
  • Matino D; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
  • Germini F; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
  • Chan AKC; IRCCS Humanitas Research Hospital, Milan, Italy.
  • Decker K; Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada.
  • Iserman E; Hamilton Health Sciences, McMaster Children's Hospital, Hamilton, Ontario, Canada.
  • Chelle P; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.
  • Edginton AN; School of Pharmacy, University of Waterloo, Waterloo, Ontario, Canada.
  • Oladoyinbo O; School of Pharmacy, University of Waterloo, Waterloo, Ontario, Canada.
  • Trinari E; School of Pharmacy, University of Waterloo, Waterloo, Ontario, Canada.
  • Keepanasseril A; Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada.
  • Iorio A; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.
Haemophilia ; 30(2): 345-354, 2024 Mar.
Article em En | MEDLINE | ID: mdl-38379181

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fator VIII / Hemofilia A Limite: Humans País como assunto: America do norte Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fator VIII / Hemofilia A Limite: Humans País como assunto: America do norte Idioma: En Ano de publicação: 2024 Tipo de documento: Article